Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Index by author

March 01, 1967; Volume 3,Issue 2
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. ADAMIČ, Š

    1. You have access
      Inhibition of Intestinal Sugar Transport by Phenolphthalein
      Š ADAMIČ and I. BIHLER
      Molecular Pharmacology March 1967, 3 (2) 188-194;
  2. ARIAS, IRWIN M.

    1. You have access
      Estimation of the Turnover Rate of Barbiturate Side-Chain Oxidation Enzyme in Rat Liver
      IRWIN M. ARIAS and ANTONIO DE LEON
      Molecular Pharmacology March 1967, 3 (2) 216-218;

B

  1. BIHLER, I.

    1. You have access
      Inhibition of Intestinal Sugar Transport by Phenolphthalein
      Š ADAMIČ and I. BIHLER
      Molecular Pharmacology March 1967, 3 (2) 188-194;
  2. BRUCHOVSKY, N.

    1. You have access
      Effects of β-Phenethyl Alcohol on Mouse L Cells in Suspension Culture
      N. BRUCHOVSKY and J. E. TILL
      Molecular Pharmacology March 1967, 3 (2) 124-132;
    2. You have access
      Effects of β-Phenethyl Alcohol on Mouse L Cells in Suspension Culture
      N. BRUCHOVSKY, S. MAK and J. E. TILL
      Molecular Pharmacology March 1967, 3 (2) 133-141;
  3. BYVOET, PAUL

    1. You have access
      Isolation and Properties of Carbonic Anhydrase from Dog Kidney and Erythrocytes
      PAUL BYVOET and AIJA GOTTI
      Molecular Pharmacology March 1967, 3 (2) 142-152;

D

  1. DE LEON, ANTONIO

    1. You have access
      Estimation of the Turnover Rate of Barbiturate Side-Chain Oxidation Enzyme in Rat Liver
      IRWIN M. ARIAS and ANTONIO DE LEON
      Molecular Pharmacology March 1967, 3 (2) 216-218;

E

  1. ESTABROOK, RONALD W.

    1. You have access
      Spectral Studies of Drug Interaction with Hepatic Microsomal Cytochrome
      JOHN B. SCHENKMAN, HERBERT REMMER and RONALD W. ESTABROOK
      Molecular Pharmacology March 1967, 3 (2) 113-123;

F

  1. FELSENFELD, H.

    1. You have access
      The Interaction between Lysozyme and Penicillin
      H. FELSENFELD and R. E. HANDSCHUMACHER
      Molecular Pharmacology March 1967, 3 (2) 153-160;

G

  1. GOTTI, AIJA

    1. You have access
      Isolation and Properties of Carbonic Anhydrase from Dog Kidney and Erythrocytes
      PAUL BYVOET and AIJA GOTTI
      Molecular Pharmacology March 1967, 3 (2) 142-152;

H

  1. HANDSCHUMACHER, R. E.

    1. You have access
      The Interaction between Lysozyme and Penicillin
      H. FELSENFELD and R. E. HANDSCHUMACHER
      Molecular Pharmacology March 1967, 3 (2) 153-160;

J

  1. JOHNSON, J. M.

    1. You have access
      Interaction of Nitrogen Mustard with Polyribonucleotides, Ribosomes, and Enzymes Involved in Protein Synthesis in a Cell-Free System
      J. M. JOHNSON and R. W. RUDDON
      Molecular Pharmacology March 1967, 3 (2) 195-203;

M

  1. MAK, S.

    1. You have access
      Effects of β-Phenethyl Alcohol on Mouse L Cells in Suspension Culture
      N. BRUCHOVSKY, S. MAK and J. E. TILL
      Molecular Pharmacology March 1967, 3 (2) 133-141;
  2. MANSOUR, TAG E.

    1. You have access
      Phosphofructokinase from the Liver Fluke Fasciola hepatica
      DEBORAH BENNETT STONE and TAG E. MANSOUR
      Molecular Pharmacology March 1967, 3 (2) 161-176;
    2. You have access
      Phosphofructokinase from the Liver Fluke Fasciola hepatica
      DEBORAH BENNETT STONE and TAG E. MANSOUR
      Molecular Pharmacology March 1967, 3 (2) 177-187;
  3. MAREN, THOMAS H.

    1. You have access
      Inhibition of Carbonic Anhydrase in Neisseria: Effects on Enzyme Activity and Growth
      EUGENE SANDERS and THOMAS H. MAREN
      Molecular Pharmacology March 1967, 3 (2) 204-215;

N

  1. NEELY, W. BROCK

    1. You have access
      Molecular Orbital Calculations on Folic Acid and Folic Acid Analogs
      W. BROCK NEELY
      Molecular Pharmacology March 1967, 3 (2) 108-112;

R

  1. REMMER, HERBERT

    1. You have access
      Spectral Studies of Drug Interaction with Hepatic Microsomal Cytochrome
      JOHN B. SCHENKMAN, HERBERT REMMER and RONALD W. ESTABROOK
      Molecular Pharmacology March 1967, 3 (2) 113-123;
  2. ROUFOGALIS, B. D.

    1. You have access
      Structural Specificity of Substrates of Acetylcholinesterase
      J. THOMAS and B. D. ROUFOGALIS
      Molecular Pharmacology March 1967, 3 (2) 103-107;
  3. RUDDON, R. W.

    1. You have access
      Interaction of Nitrogen Mustard with Polyribonucleotides, Ribosomes, and Enzymes Involved in Protein Synthesis in a Cell-Free System
      J. M. JOHNSON and R. W. RUDDON
      Molecular Pharmacology March 1967, 3 (2) 195-203;

S

  1. SANDERS, EUGENE

    1. You have access
      Inhibition of Carbonic Anhydrase in Neisseria: Effects on Enzyme Activity and Growth
      EUGENE SANDERS and THOMAS H. MAREN
      Molecular Pharmacology March 1967, 3 (2) 204-215;
  2. SCHENKMAN, JOHN B.

    1. You have access
      Spectral Studies of Drug Interaction with Hepatic Microsomal Cytochrome
      JOHN B. SCHENKMAN, HERBERT REMMER and RONALD W. ESTABROOK
      Molecular Pharmacology March 1967, 3 (2) 113-123;
  3. STONE, DEBORAH BENNETT

    1. You have access
      Phosphofructokinase from the Liver Fluke Fasciola hepatica
      DEBORAH BENNETT STONE and TAG E. MANSOUR
      Molecular Pharmacology March 1967, 3 (2) 161-176;
    2. You have access
      Phosphofructokinase from the Liver Fluke Fasciola hepatica
      DEBORAH BENNETT STONE and TAG E. MANSOUR
      Molecular Pharmacology March 1967, 3 (2) 177-187;

T

  1. THOMAS, J.

    1. You have access
      Structural Specificity of Substrates of Acetylcholinesterase
      J. THOMAS and B. D. ROUFOGALIS
      Molecular Pharmacology March 1967, 3 (2) 103-107;
  2. TILL, J. E.

    1. You have access
      Effects of β-Phenethyl Alcohol on Mouse L Cells in Suspension Culture
      N. BRUCHOVSKY and J. E. TILL
      Molecular Pharmacology March 1967, 3 (2) 124-132;
    2. You have access
      Effects of β-Phenethyl Alcohol on Mouse L Cells in Suspension Culture
      N. BRUCHOVSKY, S. MAK and J. E. TILL
      Molecular Pharmacology March 1967, 3 (2) 133-141;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 3, Issue 2
1 Mar 1967
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Editorial Board (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics